Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Innovation Pharma (IPIX)
:IPIX
IPIX Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume37.05K
Average Volume (3M)37.90K
Market Cap
$52.07K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-6.26
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding514,013,730
10 Day Avg. Volume34,783
30 Day Avg. Volume37,904
Standard Deviation0.39
R-Squared0.00017
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Innovation Pharmaceuticals News
PremiumCompany Announcements
Innovation Pharmaceuticals Inc Faces Lease Litigation Loss
PremiumCompany Announcements
Innovation Pharmaceuticals Announces Board Members’ Resignation
---
Ownership Overview
―
Insiders
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
IPIX FAQ
What was Innovation Pharma’s price range in the past 12 months?
Innovation Pharma lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Innovation Pharma’s market cap?
Innovation Pharma’s market cap is $52.07K.
When is Innovation Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Innovation Pharma’s earnings last quarter?
Innovation Pharma released its earnings results on May 10, 2018. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.02.
Is Innovation Pharma overvalued?
According to Wall Street analysts Innovation Pharma’s price is currently Overvalued.
Does Innovation Pharma pay dividends?
Innovation Pharma does not currently pay dividends.
What is Innovation Pharma’s EPS estimate?
Innovation Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innovation Pharma have?
Innovation Pharma has 514,013,730 shares outstanding.
What happened to Innovation Pharma’s price movement after its last earnings report?
Innovation Pharma reported an EPS of -$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Innovation Pharma?
Currently, no hedge funds are holding shares in IPIX
---
Company Description
Innovation Pharma
Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company. It focuses on the discover of small molecule drugs for hard to treat diseases, including drug-resistant cancers, psoriasis, autism, and inflammatory disease. The company's lead cancer compound, Kevetrin, is an anti-cancer drug which has demonstrated the ability in pre-clinical studies to regulate the p53 pathway and attack cancers. Innovation Pharmaceuticals was founded by Krishna Kumar Menon and Leo Ehrlich in June 20, 2007 and is headquartered in Beverly, MA.
---
Bioline RX Ltd Sponsored ADR
―
Soligenix
―
CytoDyn
―
Bioxcel Therapeutics
―
Atea Pharmaceuticals
―
---